Cargando…

Resuscitation Using Liposomal Vasopressin in an Animal Model of Uncontrolled Hemorrhagic Shock

BACKGROUND: Current research suggests that administration of vasopressin to patients with uncontrolled hemorrhagic shock (UHS) can avoid the detrimental effects associated with aggressive fluid resuscitation. However, vasopressin has a short half-life of 10~35 minutes in in vivo use and precludes it...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Meng-Tse Gabriel, Wang, Hsuan-Mao, Ho, Ja-An Annie, Fan, Nien-Chu, Yang, Ya-Lin, Lee, Chien-Chang, Chen, Shyr-Chyr
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4496076/
https://www.ncbi.nlm.nih.gov/pubmed/26154286
http://dx.doi.org/10.1371/journal.pone.0130655
_version_ 1782380341553528832
author Lee, Meng-Tse Gabriel
Wang, Hsuan-Mao
Ho, Ja-An Annie
Fan, Nien-Chu
Yang, Ya-Lin
Lee, Chien-Chang
Chen, Shyr-Chyr
author_facet Lee, Meng-Tse Gabriel
Wang, Hsuan-Mao
Ho, Ja-An Annie
Fan, Nien-Chu
Yang, Ya-Lin
Lee, Chien-Chang
Chen, Shyr-Chyr
author_sort Lee, Meng-Tse Gabriel
collection PubMed
description BACKGROUND: Current research suggests that administration of vasopressin to patients with uncontrolled hemorrhagic shock (UHS) can avoid the detrimental effects associated with aggressive fluid resuscitation. However, vasopressin has a short half-life of 10~35 minutes in in vivo use and precludes its use in the pre-hospital setting. To increase the half-life of vasopressin, we proposed to synthesize liposome-encapsulated vasopressin and test it in a rat model of UHS. METHODS: The film hydration method was used to prepare liposomal vasopressin consisting of: Dipalmitoylphosphatidylcholine, cholesterol, and dipalmitoyl phosphatidylethanolamine (20:20:1 mole ratio). 42 rats were subjected to UHS and randomly received 5 different treatments (vasopressin, liposomal vasopressin, lactate ringer (LR), liposome only and sham). Outcome of UHS were measured using 4 common prognostic tests: mean arterial pressure (MAP), serum lactate level, inflammatory profile and pulmonary edema. RESULTS: The dynamic light scattering results confirmed that we had prepared a successful liposomal vasopressin complex. Comparing the serum vasopressin concentration of liposomal vasopressin and vasopressin treated animals by ELISA, we found that the concentration of vasopressin for the liposomal vasopressin treated group is higher at 60 minutes. However, there was no significant difference between the MAP profile of rats treated with vasopressin and liposomal vasopressin in UHS. We also observed that animals treated with liposomal vasopressin performed indifferently to vasopressin treated rats in serum lactate level, inflammatory profile and edema profile. For most of our assays, the liposome only control behaves similarly to LR resuscitation in UHS rats. CONCLUSION: We have synthesized a liposomal vasopressin complex that can prolong the serum concentration of vasopressin in a rat model of UHS. Although UHS rats treated with either liposomal vasopressin or vasopressin showed no statistical differences, it would be worthwhile to repeat the experiments with different liposomal compositions.
format Online
Article
Text
id pubmed-4496076
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-44960762015-07-15 Resuscitation Using Liposomal Vasopressin in an Animal Model of Uncontrolled Hemorrhagic Shock Lee, Meng-Tse Gabriel Wang, Hsuan-Mao Ho, Ja-An Annie Fan, Nien-Chu Yang, Ya-Lin Lee, Chien-Chang Chen, Shyr-Chyr PLoS One Research Article BACKGROUND: Current research suggests that administration of vasopressin to patients with uncontrolled hemorrhagic shock (UHS) can avoid the detrimental effects associated with aggressive fluid resuscitation. However, vasopressin has a short half-life of 10~35 minutes in in vivo use and precludes its use in the pre-hospital setting. To increase the half-life of vasopressin, we proposed to synthesize liposome-encapsulated vasopressin and test it in a rat model of UHS. METHODS: The film hydration method was used to prepare liposomal vasopressin consisting of: Dipalmitoylphosphatidylcholine, cholesterol, and dipalmitoyl phosphatidylethanolamine (20:20:1 mole ratio). 42 rats were subjected to UHS and randomly received 5 different treatments (vasopressin, liposomal vasopressin, lactate ringer (LR), liposome only and sham). Outcome of UHS were measured using 4 common prognostic tests: mean arterial pressure (MAP), serum lactate level, inflammatory profile and pulmonary edema. RESULTS: The dynamic light scattering results confirmed that we had prepared a successful liposomal vasopressin complex. Comparing the serum vasopressin concentration of liposomal vasopressin and vasopressin treated animals by ELISA, we found that the concentration of vasopressin for the liposomal vasopressin treated group is higher at 60 minutes. However, there was no significant difference between the MAP profile of rats treated with vasopressin and liposomal vasopressin in UHS. We also observed that animals treated with liposomal vasopressin performed indifferently to vasopressin treated rats in serum lactate level, inflammatory profile and edema profile. For most of our assays, the liposome only control behaves similarly to LR resuscitation in UHS rats. CONCLUSION: We have synthesized a liposomal vasopressin complex that can prolong the serum concentration of vasopressin in a rat model of UHS. Although UHS rats treated with either liposomal vasopressin or vasopressin showed no statistical differences, it would be worthwhile to repeat the experiments with different liposomal compositions. Public Library of Science 2015-07-08 /pmc/articles/PMC4496076/ /pubmed/26154286 http://dx.doi.org/10.1371/journal.pone.0130655 Text en © 2015 Lee et al http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.
spellingShingle Research Article
Lee, Meng-Tse Gabriel
Wang, Hsuan-Mao
Ho, Ja-An Annie
Fan, Nien-Chu
Yang, Ya-Lin
Lee, Chien-Chang
Chen, Shyr-Chyr
Resuscitation Using Liposomal Vasopressin in an Animal Model of Uncontrolled Hemorrhagic Shock
title Resuscitation Using Liposomal Vasopressin in an Animal Model of Uncontrolled Hemorrhagic Shock
title_full Resuscitation Using Liposomal Vasopressin in an Animal Model of Uncontrolled Hemorrhagic Shock
title_fullStr Resuscitation Using Liposomal Vasopressin in an Animal Model of Uncontrolled Hemorrhagic Shock
title_full_unstemmed Resuscitation Using Liposomal Vasopressin in an Animal Model of Uncontrolled Hemorrhagic Shock
title_short Resuscitation Using Liposomal Vasopressin in an Animal Model of Uncontrolled Hemorrhagic Shock
title_sort resuscitation using liposomal vasopressin in an animal model of uncontrolled hemorrhagic shock
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4496076/
https://www.ncbi.nlm.nih.gov/pubmed/26154286
http://dx.doi.org/10.1371/journal.pone.0130655
work_keys_str_mv AT leemengtsegabriel resuscitationusingliposomalvasopressininananimalmodelofuncontrolledhemorrhagicshock
AT wanghsuanmao resuscitationusingliposomalvasopressininananimalmodelofuncontrolledhemorrhagicshock
AT hojaanannie resuscitationusingliposomalvasopressininananimalmodelofuncontrolledhemorrhagicshock
AT fannienchu resuscitationusingliposomalvasopressininananimalmodelofuncontrolledhemorrhagicshock
AT yangyalin resuscitationusingliposomalvasopressininananimalmodelofuncontrolledhemorrhagicshock
AT leechienchang resuscitationusingliposomalvasopressininananimalmodelofuncontrolledhemorrhagicshock
AT chenshyrchyr resuscitationusingliposomalvasopressininananimalmodelofuncontrolledhemorrhagicshock